Spero Therapeutics (SPRO) Non-Current Deffered Revenue (2021 - 2025)
Spero Therapeutics (SPRO) recorded Non-Current Deffered Revenue of $12.58 million in Q3 2025, up 6.1% from $11.85 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends
At the end of FY2024, Spero Therapeutics reported Non-Current Deffered Revenue of $12.22 million, up 12.9% from FY2023.
- Annual Non-Current Deffered Revenue has increased for three straight years, with a three-year compound annual growth rate of 11.6% (FY2021 to FY2024).
- Across earlier years, Non-Current Deffered Revenue came in at $10.83 million in FY2023 (+11.1%), $9.74 million in FY2022 (+10.9%) and $8.79 million in FY2021.
- Quarterly Non-Current Deffered Revenue has ranged from $8.79 million in Q4 2021 to $23.75 million in Q3 2023 over the past five years.
- On a year-over-year basis, Non-Current Deffered Revenue has increased for four consecutive quarters, with an average decline of 8.0% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 39.1% in Q2 2025, against a decline of 59.5% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.58 million (Q2 2025), $12.58 million (Q1 2025) and $12.22 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 12.58 Mn |
| Jun 30, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Dec 31, 2024 | 12.22 Mn |
| Sep 30, 2024 | 11.85 Mn |
| Jun 30, 2024 | 9.04 Mn |
| Mar 31, 2024 | 9.95 Mn |
| Dec 31, 2023 | 10.83 Mn |
| Sep 30, 2023 | 23.75 Mn |
| Jun 30, 2023 | 22.30 Mn |
| Mar 31, 2023 | 19.95 Mn |
| Dec 31, 2022 | 9.74 Mn |
| Dec 31, 2021 | 8.79 Mn |
API Access
Spero Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();